Wednesday, July 9, 2025
13.7 C
London
HomeFinTechSudo Biosciences: Raises $37M in Series A Financing

Sudo Biosciences: Raises $37M in Series A Financing

Date:

Revolut Expands Services: Users Can Now Send Money to China via Alipay

Revolut Enhances Global Transactions with New Alipay Integration for...

Consultation on the Future of Australian A2A Payments by AusPayNet and AP

Exploring Innovations and Developments in Account-to-Account Payment SystemsHighlights: AusPayNet...

CastellumAI Raises $8.5M to Revolutionize AI in Real Estate

Empowering Real Estate with Innovative Artificial Intelligence SolutionsHighlights: CastellumAI...

Sudo Biosciences Raises $37M in Series A Financing

  • Sudo Biosciences, a Menlo Park, CA-based biopharmaceutical company, raised $37M in Series A funding
  • The round was led by Frazier Life Sciences with participation from Velosity Capital
  • The company intends to use the funds to advance its lead drug candidates into the clinic
  • SudoBiosciences is a biopharmaceutical company focused on designing and developing medicines to improve patients’ lives. The company’s programs target the tyrosine kinase 2 (TYK2) pseudokinase domain
  • TYK2 is a key mediator in cytokine signaling pathways that have been linked to a broad range of immune-mediated inflammatory conditions
  • SudoBiosciences also has operations in Indianapolis, IN and London, UK

Related stories

spot_img

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Latest stories